New test for Hepatitis B
The new hepatitis B surface antigen (HBsAg) quant test enables physicians to assess a patient
Say something
The new hepatitis B surface antigen (HBsAg) quant test enables physicians to assess a patient
Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011.